An Extension Study to Assess the Safety, Tolerability, Efficacy, and Treatment Adherence of Dapsone in Acne Vulgaris [Extension of 700229162]
Latest Information Update: 28 Feb 2013
At a glance
- Drugs Dapsone (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- 22 Feb 2013 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov record.
- 14 Feb 2013 New trial record